Ranitidine

gastrin ; Homo sapiens







37 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 22607579 Single oral doses of netazepide (YF476), a gastrin receptor antagonist, cause dose-dependent, sustained increases in gastric pH compared with placebo and ranitidine in healthy subjects. 2012 Jul 1
2 12063974 Changes of plasma levels of gastrointestinal peptides over the course of acute pancreatitis. Any significance for the pathophysiology and treatment of acute pancreatitis? 2002 May-Jun 1
3 12503773 Effects of three H2-receptor antagonists (cimetidine, famotidine, ranitidine) on serum gastrin level. 2002 2
4 9068463 Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy. 1997 Mar 1
5 8804870 Prevention of recurrence of oesophageal stricture, a comparison of lansoprazole and high-dose ranitidine. 1996 May 1
6 7875420 [Variations of plasma gastrin (basal and postprandial) in ththtreatmentof duodenal ulcer with either enprostil or ranitidine. Correlations with rates of relapse]. 1994 2
7 8053433 Double-blind comparison of lansoprazole, ranitidine, and placebo in the treatment of acute duodenal ulcer. Lansoprazole Study Group. 1994 Aug 1
8 8180296 Long-term therapy with pantoprazole in patients with peptic ulceration resistant to extended high-dose ranitidine treatment. 1994 1
9 8281874 Effects of ranitidine 150 mg four times a day on 24-hour intragastric acidity and 24-hour plasma gastrin concentration. 1994 Jan 1
10 8101695 Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Lansoprazole Study Group. 1993 Aug 1
11 8285777 Omeprazole and high dose ranitidine in the treatment of refractory reflux oesophagitis. 1993 Dec 1
12 8472980 Effect of ranitidine bismuth citrate on postprandial plasma gastrin and pepsinogens. 1993 Mar 2
13 8490080 An open trial of long-term therapy with lansoprazole in patients with peptic ulceration resistant to extended high-dose ranitidine treatment. 1993 1
14 1427586 Gastric acid secretion and plasma gastrin during short-term treatment with omeprazole and ranitidine in duodenal ulcer patients. 1992 Aug 2
15 1736336 Effect of duodenal ulcer healing induced by omeprazole and ranitidine on the generation of gastroduodenal eicosanoids, platelet-activating factor, pepsinogen A, and gastrin in duodenal ulcer patients. 1992 1
16 1675024 Is hypergastrinaemia dangerous to man? 1991 1
17 1685675 Rebound hypersecretion after H2-antagonist withdrawal--a comparative study with nizatidine, ranitidine and famotidine. 1991 Aug 1
18 1862300 24-hour intragastric acidity and plasma gastrin during long-term treatment with omeprazole or ranitidine in patients with reflux esophagitis. 1991 Jun 1
19 1889719 Tolerance during 5 months of dosing with ranitidine, 150 mg nightly: a placebo-controlled, double-blind study. 1991 Oct 1
20 1983349 Intravenous pentagastrin can induce the illusion of 'tolerance' to a single dose of an H2-blocker in man. 1990 1
21 2093018 Efficacy and safety of omeprazole in the long-term treatment of peptic ulcer and reflux oesophagitis resistant to ranitidine. 1990 1
22 2103756 Gastric histology and plasma gastrin response to a meal in patients with duodenal ulcer disease after five years treatment with ranitidine. 1990 Aug 1
23 2277968 High doses of ranitidine in patients with reflux oesophagitis. 1990 2
24 2390929 Plaunotol inhibits postprandial gastrin release by its unique secretin-releasing action in humans. 1990 Sep 2
25 2513641 Omeprazole in the long-term management of patients with acid-related diseases resistant to ranitidine. 1989 1
26 2904394 Twenty four hour intragastric acidity and plasma gastrin concentration in healthy volunteers taking nizatidine 150 mg, nizatidine 300 mg, ranitidine 300 mg, or placebo at 21:00 h. 1988 Oct 1
27 3127265 Persistence of circadian rhythms in gastric acid, gastrin, and pancreatic polypeptide secretions despite loss of cortisol and body temperature rhythms in man under stress. 1988 Jan 1
28 3410170 Therapy with omeprazole in patients with peptic ulcerations resistant to extended high-dose ranitidine treatment. 1988 1
29 2979226 Twenty-four-hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine or omeprazole. 1987 Jun 1
30 2878726 Synergistic interaction between an H2-receptor antagonist and enprostil on 24-hour intragastric pH, serum gastrin concentration, and tissue immunoperoxidase staining for gastrin, somatostatin, and serotonin in a patient with metastatic gastrinoma. 1986 1
31 3702129 [Chronological effect of histamine H2 receptor antagonist ranitidine as serum gastrin response in gastric ulcer patients]. 1986 Jan 1
32 3818148 Inhibition of food stimulated acid secretion by association of pirenzepine and ranitidine in duodenal ulcer patients. 1986 Dec 1
33 2410935 Effects of eight-week treatment with oral ranitidine on plasma level changes of gastrin, histamine and serotonin in duodenal ulcer patients. 1985 Jun 3
34 2856908 Effects of cimetidine and ranitidine on interdigestive and postprandial lower esophageal sphincter pressures and plasma gastrin levels in normal subjects. 1985 Feb 1
35 2986474 The effect of magnesium trisilicate mixture, metoclopramide and ranitidine on gastric pH, volume and serum gastrin. 1985 Mar 3
36 6125203 Ranitidine upon meal-induced gastric secretion: oral pharmacokinetics and plasma concentration effect relationships. 1982 Aug 1
37 6293900 Effect of gastrin on fasting and postprandial plasma GIP release in man. 1982 1